Browsing Category
Healthcare Newsdesk
294 posts
Freeline Doses Second Patient of Phase 1/2 MARVEL-1 Clinical Trial for Fabry Disease
Lowest dose cohort complete and study positioned for dose escalation Company to present FLT190 data by year-end LONDON,…
Autolus Therapeutics Announces Innovation Licensing and Access Pathway (ILAP) designation for obe-cel for the treatment of relapsed/refractory adult B-cell ALL
LONDON, June 15, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed…
Vaccitech Reports First Quarter 2021 Financial Results and Recent Corporate Developments
OXFORD, United Kingdom, June 14, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged…
iosBio appoints Patricia Londono-Hayes as Chief Development Officer
PRESS RELEASE iosBio appoints Patricia Londono-Hayes as Chief Development Officer Oral vaccines and biotherapeutics company strengthens senior leadership…
Autolus Therapeutics Presents New Data on obe-cel in r/r Indolent B Cell Lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress
Obe-cel achieves 100% complete remission rate in a cohort of indolent B Cell Non-Hodgkin lymphoma patients with excellent…
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China
$40 million upfront including $25 million cash and $15 million in equity in Nuance Biotech (parent company) Up…
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in…
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
LONDON, June 08, 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated…
Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
CAMBRIDGE, Mass. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that…
Fertility Focus Announces Launch of OvuFirst Skin-Worn Sensor to Add Support for Women Starting Out on Their Journey to Pregnancy
Latest Addition to the OvuSense Family, Which Now Covers the Complete Trying To Conceive Pathway, is Proven in…
